Biotechnology Healthcare - June 2008 - (Page 2) OPENERS EDITOR Michael D. Dalzell EDITOR IN CHIEF, EDITORIAL ADVISORY BOARD Winds of Change Michael D. Dalzell David B. Nash, MD, MBA SENIOR EDITOR Katherine T. Adams SENIOR EDITOR, CUSTOM PUBLICATIONS Amy Krajacic SENIOR CONTRIBUTING EDITORS A Amanda Brower Bob Carlson, MHA John Carroll Jack McCain CONTRIBUTING EDITORS Lola Butcher Scott Kober WEB EDITOR Tony Berberabe, MPH DESIGN DIRECTOR Philip Denlinger PRESIDENT AND GROUP PUBLISHER Timothy J. Stezzi PRESIDENT AND GROUP PUBLISHER Timothy P. Search, RPh EASTERN SALES MANAGER Scott MacDonald SENIOR ACCOUNT MANAGER Kenneth D. Watkins III DIRECTOR, PRODUCTION SERVICES Waneta Peart CIRCULATION MANAGER Jacquelyn Ott The articles in BIOTECHNOLOGY HEALTHCARE are reviewed by appropriate members of the editorial board and/or other qualified experts. The opinions are those of the authors and do not necessarily represent those of the institutions that employ the authors, BioCommunications LLC, or the publisher, editor, or editorial board. Clinical judgment must guide each clinician in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this publication may reflect the clinical experience of the authors, or may reflect the professional literature or other clinical sources, and may not be the same as indicated on the approved package insert. Please consult the complete prescribing information on any products mentioned in this publication. BioCommunications LLC assumes no liability for the information published herein. French proverb says that Today, we extend our mission to emwhen it comes to changes, ployers. Feature articles and departpeople like only the ones ments will demystify the world of biothey make themselves. But logics so that purchasers can collaborate the changes transforming healthcare with their payer partners to make inand information technology hold great formed and rational decisions. The promise for improving our health and upper right corner of our cover spells our ability to learn. BIOTECHout our intent: To explore Biotechnology the impact of biologics on NOLOGY HEALTHCARE is Healthcare health, business, and benepoised to help you make the fits. The story “teasers” on most of these developments. the cover tell you how we’ll By the late ’90s, power in do that. healthcare had shifted from Our second big change physicians to payers. The lies in how we present our managed care backlash that content to you. With this followed resulted in another issue, we are launching an power shift — to purchasers. interactive digital edition of Having abandoned the preBIOTECHNOLOGY HEALTHCARE. To see it, scriptive approach, health plans now ask their employer clients, “What kind visit the link on our Web site, «www. of benefit plan can we design for you?” biotechnologyhealthcare.com». That sounds like a change most peoThe digital edition is nothing like a ple would embrace, but when it comes Web page — it’s not a static page of to biologics, most employers don’t html. As you read our stories, notice know enough about them to respond the flash animation and the jumps to thoughtfully. Without an appreciation of articles inside the publication. Roll your mouse across the ads to discover Web the value proposition of biologics, withlinks and product information. A digiout knowing what questions to ask, and without the scientific training to evalutal edition can be e-mailed to you to ate outcomes against cost, many corporead when and wherever you like. rate chief financial officers understand This is just a toe in the water. As we only one thing: Biologics are costly. ourselves learn how to use the power of That leads to arbitrary decisions, perthe technology, we’ll swim into the haps to the detriment of productivity. deep end: Bonus content not available Therein lies our first big change. in the print edition, audio and video Since its beginning, BIOTECHNOLOGY feeds, PowerPoint downloads, interactive features for reader response. The HEALTHCARE has been a guide for decipossibilities, as they say, are endless. sion makers to the biotechnology revoWe hope you like the changes. lution. We educate readers about biologics and serve as a forum for payer executives to learn from their peers about how best to manage the benefit. THE IMPACT OF BIOLOGICS ON HEALTH, BUSINESS, AND BENEFITS MAY/JUNE 2008 www.biotechnologyhealthcare.com Cancer Research: What Does It Mean to You? Translating clinical trial endpoints into considerations for benefit design and plan coverage Page 22 A Day in the Lives Of Specialty Drug Decision Makers Page 42 Spot the Evidence For Molecular Tests Page 36 Biologic Benefit Design Based On Clinical Need Page 52 CONTACT E-MAIL ADDRESSES: Editors: editors@biotechnologyhealthcare.com Circulation: biotechnologyhealthcare@icnfull.com Advertising: advertising@biotechnologyhealthcare.com Reprints: reprints@biotechnologyhealthcare.com 2 BIOTECHNOLOGY HEALTHCARE · MAY/JUNE 2008 http://www.biotechnologyhealthcare.com http://www.biotechnologyhealthcare.com http://www.biotechnologyhealthcare.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.